Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Immunovant Sciences GmbH
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Participants who completed Study IMVT-1402-2502 or Study IMVT-1402-2503.
You may not be if
Have permanently discontinued IMP during the treatment period in the feeder study or have met study stopping criteria at any point up until the end of participation in the feeder study.
